NCT05308433 (CANOE) is a NA clinical trial of Functional MRI in Healthy, sponsored by Central Hospital, Nancy, France.

Who is sponsoring NCT05308433?

NCT05308433 is sponsored by Central Hospital, Nancy, France.

What drugs are being tested in NCT05308433?

Interventions in NCT05308433: Functional MRI, Virtual Reality: control, Virtual Reality: experimental.

Is NCT05308433 still recruiting?

NCT05308433 is currently completed. Last updated 7 November 2022.

Last reviewed 2022-11-07 · How we verify

NCT05308433: CANOE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Cybersickness imAgiNg Olfactory Evocation

Completed NA Last updated 7 November 2022

What this trial tests

NA trial testing Functional MRI in Healthy in 30 participants. Completed in 26 October 2022.

Timeline

13 April 2022

Primary endpoint
12 July 2022

26 October 2022

Quick facts

Lead sponsor	Central Hospital, Nancy, France
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	30
Start date	13 April 2022
Primary completion	12 July 2022
Estimated completion	26 October 2022
Sites	1 location across France

Drugs / interventions tested

Functional MRI
Virtual Reality: control
Virtual Reality: experimental

Conditions studied

Healthy — all drugs for Healthy →

Sponsor

Central Hospital, Nancy, France

Who can join

Adults 18 to 50, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to, using fMRI, compare brain activations during olfactory imagery induced by different visual supports (words, pictures, colors and colored arrangements) in healthy subjects. This will allow us to choose the best olfactory imagery facilitator and to assess its effect on cybersickness.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Semantical Visual Information Facilitates Odor Imagery: A Combined Neurophysiological and Psychometrical Approach.
Fantin L, Ceyte H, Rumeau C, Drouot G, et al · · 2025 · cited 1× · PMID 40898763 · DOI 10.1002/brb3.70835
Is it all in your head? Reducing virtual reality induced cybersickness by pleasant odor imagery.
Fantin L, Hossu G, Rumeau C, Drouot G, et al · · 2025 · PMID 40067876 · DOI 10.1371/journal.pone.0319661

Verify or expand the search:

Other trials of Functional MRI

Trials testing the same drug.

NCT06797661 — Insights Into the Pathophysiology of Neurovascular Uncoupling in Patients with Brain Lesions. · NA · recruiting
NCT06506019 — Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar Depression · Phase 1 · recruiting
NCT06471179 — Functional Magnetic Resonance Imaging Study in Schizophrenia Patients and Correlation With Cognitive Impairments · not yet recruiting
NCT06355284 — Overcontrol and Suicide in PTSD · active not recruiting
NCT05498532 — Functional MRI Evaluation in Pyeloureteral Junction Syndrome in Children · unknown

Other recruiting trials for Healthy

Currently open trials in the same condition.

NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting

Other Central Hospital, Nancy, France trials

Trials by the same sponsor.

NCT06452290 — PET Biomarker Study for Antidepressant Response Prediction in Major Depressive Disorder · NA · not yet recruiting
NCT07518498 — Hypnosis During Mechanical Ventilation Weaning · NA · not yet recruiting
NCT07471334 — Prospective Study of Postictal Psychotic Symptoms Occuring After Video-EEG Monitoring in Focal Epilepsies · NA · not yet recruiting
NCT07414667 — Primary Sjögren's Syndrome: Impact of Quantitative Anti-Ro52 Antibody Analysis on Patient Prognosis and Stratification ( · not yet recruiting
NCT07415759 — Imaging of Electrical Properties by MRI: Investigation of Age-Related Changes · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05308433 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Central Hospital, Nancy, France
Last refreshed: 7 November 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05308433.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing